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ABSTRACT In a previous paper we described the induc-
tion by x-irradiation or radiation-induced leukemia virus-in-
oculation of two classes of lymphoid T-cell neoplasms: The
first class, designated T-cell lymphoblastoma (TCLB), consists
of growth-factor-dependent eudiploid cells that home to the
spleen and give rise to splenic tumors on injection into synge-
neic mice; the second class, designated T-cell lymphoma
(TCL), consists of growth-factor-independent aneuploid or
pseudodiploid cells that give rise to local tumors at the site of
subcutaneous injection. This paper describes the generation of
a family of growth-factor-independent aneuploid or pseudodi-
ploid TCL cells after the injection into the thymus of growth-
factor-dependent diploid TCLI cells. In contrast to the donor
TCLB cells, the resulting TCL cells could be cloned in semisol-
id medium, produced local tumors at the site of subcutaneous
injection, and proliferated in a growth-factor-independent
fashion in vitro. The induced growth-factor-independent TCL
cells were chromosomally and phenotypically unstable and
continued to evolve both in vivo and in vitro. After propagation
in the thymus, the cells often showed stable translocations in
addition to the evolving aneuploidy. We propose that the chro-
mosome abnormalities induced during the proliferation of
growth-factor-dependent TCLB cells in the thymus constitute
a general mechanism by which neoplastic cells progress from
growth-factor dependency to independency.
The mechanism of evolution of T-cell lymphomas (TCL)
within the thymus of systemically irradiated or radiation-in-
duced leukemia virus (RadLV)-inoculated C57BL/6 (B6)
mice is as yet unknown. Some models suggest that in the
preneoplastic thymus there exists a continuing regenerative
hyperplasia of cells leading to neoplasia, with the subsequent
crowding out of the normal lymphocytes by neoplastic lym-
phoblasts (1). This mechanism is based on the existence in
treated mice of potentially neoplastic cells that would evolve
to become neoplastic TCL cells by propagation in the thy-
mus. Potentially neoplastic cells have been shown in system-
ically irradiated (2, 3) as well as in RadLV-inoculated mice
(4) using a transplantation bioassay in which hematopoietic
cells taken from treated mice were injected into genetically
marked recipients.
While one can thus show the presence of potentially neo-
plastic cells long before lymphoma development, the loca-
tion of such cells in irradiated mice is a matter of contention.
Some investigators have detected potentially neoplastic cells
in the thymus although not in the bone marrow of irradiated
mice (3); others have found preleukemic cells primarily
among bone marrow cells but not in the thymus (5). Further-
more, few properties of potentially neoplastic cells are
known (6, 7) because they have neither been grown nor oth-
erwise isolated from the putative organs of their in vivo resi-
dence.
We have propagated and cloned in culture a class of T
lymphoblasts from the spleens and lymph nodes of irradiated
or RadLV-inoculated mice long before these had developed
a thymic lymphoma (8). These neoplastic cells (T-cell lym-
phoblastoma; TCLB) precede the appearance ofthymic lym-
phomas by 6-10 weeks. The isolation of these TCLB cells (8)
suggests that they, or cells possessing similar properties,
may be precursors to a class of autonomous neoplastic TCL
cells. TCLB cells are distinct from thymic TCL cells in the
following ways: (i) They are growth-factor dependent, auto-
stimulating [producing their own growth factor(s)], and eudi-
ploid; and (ii) they do not form colonies in soft agar unless
the cultures are supplemented with exogenous conditioned
medium. When injected in vivo, TCLB cells give rise to sple-
nic tumors. Their tumorigenicity depends on the fact that
they home to the spleen; they do not induce tumors at the
site of subcutaneous inoculation. These characteristics of
TCLB cells have been stable through prolonged propagation
in vitro in mass culture, through cycles of single-cell cloning,
and through repeated in vivo (splenic) passage.
In contrast, x-ray- or virus-induced thymic TCL are often
monoclonal and are composed of chromosomally abnormal,
growth-factor-independent (i.e.; autonomously growing)
-cells. TCL cells can be quantitatively cloned in soft agar
without added growth factors and produce tumors at the site
of subcutaneous inoculation in vivo. TCL cells are often tri-
somic for chromosome 15.
On the basis of their growth-factor-dependent prolifera-
tion, their stable eudiploid karyotype, as well as their lack of
cloning in methyl cellulose and their organ-dependent prolif-
eration in vivo, TCLB cells can be classified as "benign"
cells. In contrast, thymic TCL cells possess the characteris-
tics of "malignant" cells, which grow autonomously and of-
ten metastasize.
After systemic x-irradiation or RadLV inoculation of B6
mice, growth-factor autonomous thymic lymphomas appear
with a latency of 3-5 months, a latency that has not been
satisfactorily explained. We surmised that cells possessing
characteristics similar to the growth-factor-dependent TCLB
cells might constitute natural precursors to a class of thymic
TCL cells. If so, then continuing proliferation ofTCLB cells
in the thymus might lead to the selection of cells transformed
into growth-factor-independent TCL cells. Here we report
that intrathymic inoculation of cloned TCLB cells did induce
rapidly growing thymic lymphomas composed of donor cells
Abbreviations: TCLB, T-cell lymphoblastoma; TCL, T-cell lympho-
ma; RadLV, radiation-induced leukemia virus.
1742
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked "advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Proc. Nati Acad Sci. USA 81 (1984) 1743
that had been drastically altered by proliferation in the thy-
mus. Cells of thymic lymphomas that were derived after in-
trathymic inoculation of TCLB cells could be cloned in semi-
solid medium, grew into local tumors at the site of subcuta-
neous injection and were aneuploid in contrast to the eudi-
ploid, growth-factor-dependent donor TCLB cells. After
proliferation in the thymus, the cells often showed chromo-
somal translocations in addition to the evolving aneuploidy.
Such lymphomas could develop from injection of an average
of one TCLB cell. TCLB cells that had been propagated in
the thymus thus had acquired many of the properties of radi-
ation- or virus-induced thymic TCL cells, suggesting that
propagation of immortalized T-cell blasts in the thymic mi-
croenvironment is necessary and may be sufficient for the
generation of growth-factor-independent TCL cells.
MATERIALS AND METHODS
Tumor Cells. The induction of lymphomas by irradiation
or virus-inoculation of B6 mice has been described (8). Es-
tablishment ofTCLB and TCL cell lines in culture, as well as
their cloning in semisolid medium, has also been described
(8).
Intrathymic Inoculation of Cloned TCLB Cells. Mice inject-
ed intrathymically with TCLB cells develop rapidly growing
thymic tumors. From the time enlarged thymuses could be
palpated (thymus size, 300-400 mg; 16-18 days after injec-
tion) to the time of death (thymus size, 2-3 g), only 2-3 days
elapsed. X-irradiated or virus-inoculated leukemic mice nor-
mally die 30-40 days after the first detection of thymic lym-
phomas by palpation. Mice that were inoculated intrathymi-
cally with an average of one TCLB cell and that died 20 days
later with a thymic tumor of 3 g had experienced =32 cell
doublings. This would indicate an average maximum dou-
bling time of 16 hr. However, normal cells in the thymus are
reported to have a high rate of proliferation and attrition (9),
suggesting that injected TCLB cells proliferate in the thymus
at an even higher rate.
Cell Cloning in Methyl Cellulose. Cells were plated in 5-cm
dishes in 0.8% methyl cellulose in Dulbecco modified Ea-
gle's medium (DME medium) on top of a bottom layer of
1.1% agar in DME medium/10% fetal bovine serum. Rou-
tinely, 104 or 2 x 104 viable cells were plated per 5-cm dish.
Karyotype Analysis. Cells were incubated for 2 hr at 37°C
in medium containing 0.025 ,ug of colcemid per ml. They
were then centrifuged at 150 x g in a clinical centrifuge for 6
min. After aspiration of the medium, the pelleted cells were
gently resuspended in 5 ml of 0.75 M KCl for 30 min during
which time the cell suspension was mixed continually. Five
A
milliliters of freshly prepared fixative (methyl alcohol/gla-
cial acetic acid, 2:1) was added to the cell suspension. The
suspension was allowed to stand for 5 min at room tempera-
ture. After two changes of fixative, the cells were placed on
glass slides for analysis. G-banding was analyzed after brief
exposure to 0.5% trypsin and subsequent staining with
Giemsa.
RESULTS
Thymic Versus Splenic Propagation of TCLB Cells. TCLB
lines maintain their genotype when propagated for extended
time periods in culture, when cloned in methyl cellulose in
the presence of exogenous growth factor, and on splenic
propagation in vivo (8). Intraperitoneal inoculation of 104
TCLB cells (female cell line 18-28-4SPL) into male syngene-
ic B6 mice induced splenic tumors of donor cell origin. (LD50
= 5000 cells for i.p. inoculation in 6-week-old B6 mice.)
Upon return of these cells to culture no differences were de-
tected between the inoculated cells and the cells that had
been passaged through the spleen. The cells were growth-
factor dependent, growth-factor secreting, autostimulating,
and eudiploid. The phenotype of the specific line used (TL-
1-2-4-, TdT-, Lyt-1+2-3-, Thy-1+, IL-2+) was stable
through in vivo (splenic) passage (8). Furthermore, expres-
sion of a panel of oncogenes by TCLB cells did not change
after in vitro cloning or in vivo splenic propagation (unpub-
lished observations).
In contrast, inoculation of TCLB cells into the thymus
gave rise to significant genotypic and phenotypic changes in
the cells. Male B6 mice in groups of 10 were inoculated in-
trathymically with 200, 20, or (on the average) 1 female
TCLB cells. (LD50 10 cells for intrathymic inoculation into
6-week-old B6 mice.) From 16 to 18 days after inoculation,
the mice developed large (2-3 g) thymic tumors that were
explanted in vitro, grown for five to eight transfers (12-20
days; 18-30 cell doublings), and studied by karyotyping,
cloning in methyl cellulose, growth-factor dependency,
growth in vivo, interleukin 2 production, and cell markers.
The genotypic and phenotypic changes that were induced by
thymic propagation of TCLB cells are described below.
Cell Cloning in Semisolid Medium of Derived TCL Cells.
Fig. LA shows clones in semisolid medium ofTCL cells after
intrathymic inoculation of 20 TCLB cells. Viable cells (2 x
104) from early mass cultures of thymus-passaged TCLB
cells ("derived" TCL cells) were plated in methyl cellulose.
As controls, 2 x 104 TCLB cells that had been grown in cul-
ture but had not been passaged through the thymus were
similarly plated. A variable fraction (0.05-0.5%) of cells that
II
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FIG. 1. (A) Soft-agar clones of TCL cells that were derived by inoculation of TCLB cells in the thymus. Mouse A3 was inoculated intrathy-
mically with 20 cloned TCLB cells. Nineteen days after inoculation, the resulting thymic tumor was removed and explanted in mass culture.
When a suspension lymphoid culture was obtained (at transfer no. 8), 2 x 104 cells were plated in 0.8% methyl cellulose on an agar bottom layer
in DME medium containing 10% fetal bovine serum. A control culture in which 2 x 104 donor TCLB cells were similarly plated in semisolid
medium is shown on the left. (B) Flow microfluorimeter analysis of the DNA content of TCL cultures derived by proliferation of TCLB cells in
the thymus. Cells of TCL mass cultures C7 (Left) and B1 (Right) derived by thymic proliferation of TCLB cells were stained with the DNA-
binding dye mithramycin (10, 11) and were analyzed for fluorescence intensity (DNA content) by flow microfluorometry. Eudiploid cloned
TCLB cells were analyzed at the same time and their fluorescence distributions were superimposed on the screen and photographed.
Cell Biology: Haas et aL
I
1744 Cell Biology: Haas et al.
had been propagated in the thymus produced colonies in
methyl cellulose, while the TCLB cells could not be cloned
in semisolid cultures (frequency, <10-6).
After thymic propagation of the eudiploid TCLB cells, the
average DNA content per cell increased significantly. Thy-
mus-derived TCL cells (107) in mass culture were stained
with the DNA-binding fluorescent dye mithramycin. The
DNA content per cell was estimated by flow microfluori-
metry and was compared to the DNA content of similarly
stained TCLB cells. Mithramycin fluorescence intensity is
proportional to DNA content (10, 11). Cell cycle analysis
and fluorescence intensity of the cells in G1 phase indicated
that mass cultures of TCL cells that were derived by intra-
thymic inoculation of TCLB cells contained 4.5-6% more
DNA than the precursor TCLB cells, as is shown in Fig. 1B.
This indicated that thymus-propagated TCLB cells pos-
sessed an increased DNA content per cell as compared to
the parental TCLB cells. In control experiments, flow mi-
crofluorimetry analysis of the DNA content ofTCL cells tri-
somic for chromosome 15 was compared to that of eudiploid
TCLB cells, which showed that the trisomic TCL cells con-
tained an average of 4.9% more DNA than diploid TCLB
cells (not shown).
Induction of Chromosomal Abnormalities by Proliferation
of TCLB Cells in the Thymus. Table 1 summarizes chromo-
some counts ofTCL cells derived by intrathymic inoculation
of TCLB cells into male mice and reisolation of cells from
the resulting thymic tumors. After proliferation in the thy-
mus, the explanted mass cultures contained almost exclu-
sively chromosomally abnormal cells, mostly containing 40
(pseudodiploid) or 41 chromosomes (Table 1). In contrast,
TCLB cells that were propagated through the spleen (i.p.
inoculation, reisolation from the spleen) were genetically
and phenotypically stable (Table 1; ref. 8). Most of the cells
that were propagated through the thymus and that possessed
40 chromosomes were pseudodiploid and chromosomally
quite abnormal, as is shown in Table 2. Deviations from the
eudiploid karyotype were mostly attributable to nondisjunc-
tion, although translocations have also been observed. The
chromosomes that were most often subject to loss or gain
were (with declining frequency) chromosomes 14, 15, 16, 3,
and 4 (data not shown). Few cells that were trisomic for
chromosome 15 were initially encountered among the TCL
cells derived by propagation of TCLB cells in the thymus.
An example is the thymic tumor of mouse D1 that was
induced in the thymus by injection of (an average of) one
Table 1. Chromosome counts of TCLB cells after their
transplantation in the thymus
Number of cells with n chromosomes
per cell
Thymoma culture 39 40 41 42 43 Polyploid
Al 9 1
A2 7 3
A2s 1 8
A3 1 8
A6 10 1
A7 6 6
B1 9 1
B2 1 8 1
B3 1 10
B6 6 4
B7 1 8 1
Dl-l through Dl-10 2 37 29 7 2 10
El 3 1
TCLB-4SPL 1 16
Cells were explanted in vitro and grown for five to eight transfers
in mass culture. Cloned eudiploid female TCLB cells (cell line
4SPL) were inoculated intrathymically into male syngeneic B6 mice.
The number of cells injected per thymus was 20 (A), 200 (B), or 1 (D
and E). Chromosome counts of the donor cells before intrathymic
inoculation are shown on the bottom line. One mouse, A2, also de-
veloped a splenic T-cell neoplasm, due to the spilling ofTCLB cells
during injection of the cells into the thymus. Cells of the splenic
mass culture (A2s) were identical to the donor eudiploid TCLB
cells, while cells of the thymic tumor were aneuploid or pseudodi-
ploid.
TCLB cell (Fig. 2). Of nine single cell clones of the D1 tumor
that were grown in methyl cellulose and analyzed, seven
contained the translocation in chromosome 4. The source of
the translocated segment has not yet been determined. Like
other tumors that were derived by injection of TCLB cells
into the thymus, the TCL mass culture D1 also displayed
considerable chromosome instability over and above the sta-
ble translocation in chromosome 4 (Table 2; Fig. 2). Chro-
mosome instability and the induction of aneuploidy and
translocations have been observed after inoculation of two
other independently isolated TCLB cell lines into the thymus
of mice (not shown).
Once explanted and cloned, the derived TCL cells contin-
ued to show chromosomal instability in culture. Recloning of
Table 2. Some examples of karyotypes of TCLB cells after transplantation in the thymus
3+ 5- 9+
4- 6+
Normal
5- 9+
7-
3-
3+
4-
t(4) 6+7-
t(4) 6+ 8+
t(4) 6+
t(4) 7+ 9+
t(4) 8-
Normal diploid
Karyotype
14-
14+
8 l1++
11+
18-19+
14+ 16+
14- 16-17+18-
15-
13+14-
15+
16-
10+11- 12- 14+
12- 15+ 17+
13+ 16+ 17+ 18-
Culture
A6
A7
A8
B1
B3
B6
C3
D1-1
D1-9
TCLB-4SPL
No. of
chromosomes
40
41
40
40
41
41
41
40
41
41
41
43
42
40
Cloned, normal diploid female TCLB cells (cell line 4SPL) were inoculated into the thymus of male syngeneic B6 mice. The number of cells
injected per thymus was 20 (A), 200 (B), or 1 (D and E). Chromosome counts of the donor cells before intrathymic inoculation are shown on the
bottom line. Translocation of the chromosomal segment of unknown origin to chromosome 4 has been observed (see Fig. 2). Data for cell clones
D1-1 and D1-9 refer to cells that were twice cloned in methyl cellulose, then grown in mass culture, and prepared for karyotyping. All cells were
of donor (female) origin.
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FIG. 2. Karyotypes of thymus-induced TCL cells of clones D1-1 (A) and D1-9 (B and C). Clones in methyl cellulose were grown from the
thymus-induced TCL mass culture D1 (derived by intrathymic inoculation of an average of a single TCLB cell). Cells of clones D1-1 through
Dl-10 had unstable karyotypes. Karyotypes of one cell of clone D1-1 and two cells of clone D1-9 are shown. These possessed the karyotypes
indicated in Table 2.
the cells in soft agar revealed new aneuploid or pseudodi-
ploid segregants from a single clone. This was also the case
for the D1 tumor cells when passaged in culture (Fig. 2; Ta-
ble 2). The instability of the derived TCL cells is notable in
comparison to the phenotypic and genotypic stability in vivo
and in vitro of the eudiploid TCLB cells. It also contrasts
with the stability of the TCL cells trisomic for chromosome
15, which were isolated from frank thymic lymphomas after
a 3-5 month period of latency (8).
Tumorigenic Properties of Derived TCL Cells. After prolif-
eration of TCLB cells in the thymus, derived TCL cells pro-
duced tumors at the site of subcutaneous injection. Mass cul-
tures were established from thymic tumors induced by in-
trathymic inoculation of (an average of) one TCLB cell. The
resulting TCL cells were cloned in methyl cellulose and 10
clones were picked at random and grown. Cells (104) of
clones D1-1 to Dl-10 were injected subcutaneously into
groups of 6-week-old male mice. The cloned derived TCL
cells gave rise to walnut-sized subcutaneous tumors at the
site of injection in 100% of injected mice in 2 weeks. In con-
trol groups, no local tumors developed in mice similarly in-
jected with 104 TCLB cells, although 9 out of 10 of the con-
trol mice developed splenic tumors in 5-6 weeks.
DISCUSSION
We have previously shown (8) that x-irradiated mice or mice
that had been inoculated with RadLV often harbor two sta-
ble distinct T-cell neoplasms, one composed of growth-fac-
tor-dependent eudiploid TCLB cells that did not grow under
the skin of mice or clone in semisolid medium, and a thymic
neoplasm composed of growth-factor-independent, mono-
clonal, trisomic TCL cells, which generated local subcutane-
ous tumors at the site of inoculation and could be quantita-
tively cloned in semisolid medium. We have designated the
corresponding tumors T-cell neoplasms of phase I (lympho-
blastomas), and phase III (lymphomas), respectively. The
cells of phase I neoplasms and the cells of phase III neo-
plasms bred true through growth in vitro and in vivo as long
as phase I cells were not propagated through the thymus.
Inoculation into the thymus of one or a few cloned TCLB
cells generated a family of donor-derived aneuploid or pseu-
dodiploid neoplastic T cells. Among 120 cells that have been
karyotyped, 117 cells were of female donor origin, while 3
cells had lost one X chromosome. None of the cells studied
had a Y chromosome and was of recipient (male) origin. Un-
like the donor TCLB cells (phase I) or the often-described
(phase III) TCL cells that are trisomic for chromosome 15
(12-14), the thymic tumors that were derived by inoculation
of TCLB cells were genotypically highly unstable. They had
properties intermediate between the stable phases I and III
T-cell neoplasms. Therefore, we will refer to the thymic neo-
plastic cells that were derived by inoculation of TCLB cells
into the thymus as phase II TCL neoplastic cells.
Phase II TCL cells were chromosomally highly unstable.
Even within single cell clones grown in semisolid medium,
many different chromosomal abnormalities were found. Re-
cloning gave rise to an additional spread of aneuploid cells. It
is not yet clear whether chromosomally stable TCL cells can
be isolated in vitro from a population of genetically unstable,
evolving, phase II TCL cells, or how many cycles of single-
cell cloning are required to select for putative genetically sta-
ble TCL clones. Nor is it clear what the genotype(s) of such
stable clones will be.
Analysis of the karyotypes of phase II TCL cells indicates
6 1. 1.
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that mostly they resulted via nondisjunction. Proliferation of
TCLB cells in the thymus often resulted in the induction of
stable chromosome translocations (Fig. 2), which were su-
perimposed on a continuously evolving aneuploidy. We pro-
pose that the induction of chromosome abnormalities that is
associated with the proliferation of growth-factor-dependent
T blasts in the thymus plays a central role in the generation
of growth-factor-independent monoclonal TCL cells.
Through selection among many possible aneuploid and pseu-
dodiploid cells, growth-factor-independent genetically stable
cells may grow and give rise to apparently monoclonal thy-
mic TCLs. Furthermore, specific mutations that are generat-
ed as a result of this chromosomal instability may be re-
quired for the fixation of a stable genotype. The generation
of growth-factor-independent genetically stable TCL cells
possessing a trisomy of chromosome 15 that has been ob-
served in murine thymic lymphomas (8, 15-17) may there-
fore be the end result of the process described here-name-
ly, the generation of organ-specific genetic havoc that is in-
duced by the thymic microenvironment.
In contrast to the genetic instability of the experimentally
derived phase II TCL cells, thymic lymphomas that are in-
duced by x-irradiation, virus-inoculation, or by chemicals
have been reported to be composed of stable trisomic cells
(12-19); the class of chromosomally unstable phase II TCL
cells has not been described. Phase II thymic TCL cells may
not have been observed previously because a cell transplan-
tation step was used in the preparation of the TCL cells for
karyotyping (14-17). Such transplantation selects for the
growth-factor-independent trisomic TCL cells. By avoiding
the transplantation step, we have found that many (>60%) x-
ray-induced and virus-induced thymic TCL cells are com-
posed of genetically unstable, phase II lymphoma cells. Neo-
plastic T cells of phase II are often found in thymic lympho-
mas of x-irradiated and virus-inoculated mice, and thus are
not an experimental artefact (unpublished results).
It is not known how the thymic microenvironment induces
chromosomal abnormalities in proliferating TCLB cells. One
can envisage a positively acting mechanism (e.g., by means
of a thymus-specific growth factor) or a negatively acting
mechanism: forced proliferation in the absence of growth
factor(s) may induce unbalanced growth and chromosome
abnormalities. In addition, the replication of mink-cell focus-
inducing thymotropic virus may contribute to the observed
genetic havoc. Even if the first aberrant mitoses are trig-
gered by the thymic microenvironment, it is striking that
they continue when the cells are removed from it. What is
imposed or derepressed in the thymus is not a transient re-
sponse to environmental conditions but rather a long-term
genetic instability. The mechanism of thymus-induced chro-
mosome abnormalities should be experimentally testable
now that TCLB cells that are susceptible to the thymic mi-
croenvironment are available in vitro.
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